The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Related News Articles

Insights and Analysis
Kathleen Hackett, R.N., a nurse at University Hospitals Rainbow Babies…
Insights and Analysis
Also in this roundup of nursing news: two nurses save the life of a man struck by an SUV; and executive moves in the field.
Headline
Derrick Jones, CEO of Lovelace Rehabilitation Hospital in Albuquerque, N.M., will serve as 2019 chair of the AHA's Section for Long-Term Care and…
Insights and Analysis
Also in this roundup of hospital and health system leadership changes: Decatur County Hospital names CEO, and UNC Lenoir Health Care taps new CEO to begin in…
Chairperson's File
When our paths cross in the year ahead, I ask you to share what is on your mind, what keeps you up at night, and how we can work together to ensure that all…
Headline
Joseph Miller, vice president of behavioral health care transformation services at Hackensack (N.J.) Meridian Health, will serve as 2019 chair of the AHA's…